Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Keynote Address (November 2016): Zika Virus Disease in the Americas: A Storm in the Making.

Etienne C, Santos TD, Espinal MA.

Am J Trop Med Hyg. 2017 Jul;97(1):16-18. doi: 10.4269/ajtmh.17-0207.

2.

Zika Virus Transmission-Region of the Americas, May 15, 2015-December 15, 2016.

Ikejezie J, Shapiro CN, Kim J, Chiu M, Almiron M, Ugarte C, Espinal MA, Aldighieri S.

Am J Transplant. 2017 Jun;17(6):1681-1686. doi: 10.1111/ajt.14333. No abstract available.

3.

Zika Virus Infection and Associated Neurologic Disorders in Brazil.

de Oliveira WK, Carmo EH, Henriques CM, Coelho G, Vazquez E, Cortez-Escalante J, Molina J, Aldighieri S, Espinal MA, Dye C.

N Engl J Med. 2017 Apr 20;376(16):1591-1593. doi: 10.1056/NEJMc1608612. Epub 2017 Mar 29. No abstract available.

4.

Zika Virus Transmission - Region of the Americas, May 15, 2015-December 15, 2016.

Ikejezie J, Shapiro CN, Kim J, Chiu M, Almiron M, Ugarte C, Espinal MA, Aldighieri S.

MMWR Morb Mortal Wkly Rep. 2017 Mar 31;66(12):329-334. doi: 10.15585/mmwr.mm6612a4.

5.

Zika Virus and the Guillain-Barré Syndrome - Case Series from Seven Countries.

Dos Santos T, Rodriguez A, Almiron M, Sanhueza A, Ramon P, de Oliveira WK, Coelho GE, Badaró R, Cortez J, Ospina M, Pimentel R, Masis R, Hernandez F, Lara B, Montoya R, Jubithana B, Melchor A, Alvarez A, Aldighieri S, Dye C, Espinal MA.

N Engl J Med. 2016 Oct 20;375(16):1598-1601. Epub 2016 Aug 31. No abstract available.

6.

Operational research to strengthen tuberculosis control in the Americas.

Becerra-Posada F, Espinal MA, Reeder J.

Rev Panam Salud Publica. 2016 Jan;39(1):1-2. No abstract available.

7.

Twenty Years of Global Surveillance of Antituberculosis-Drug Resistance.

Zignol M, Dean AS, Falzon D, van Gemert W, Wright A, van Deun A, Portaels F, Laszlo A, Espinal MA, Pablos-Méndez A, Bloom A, Aziz MA, Weyer K, Jaramillo E, Nunn P, Floyd K, Raviglione MC.

N Engl J Med. 2016 Sep 15;375(11):1081-9. doi: 10.1056/NEJMsr1512438. No abstract available.

8.

Late Maternal Deaths and Deaths from Sequelae of Obstetric Causes in the Americas from 1999 to 2013: A Trend Analysis.

de Cosio FG, Jiwani SS, Sanhueza A, Soliz PN, Becerra-Posada F, Espinal MA.

PLoS One. 2016 Sep 14;11(9):e0160642. doi: 10.1371/journal.pone.0160642. eCollection 2016.

9.

Tuberculosis control.

del Granado M, López R, Victoria J, Volz A, Tenorio A, Espinal MA.

Lancet. 2016 Mar 19;387(10024):1158. doi: 10.1016/S0140-6736(16)00707-8. No abstract available.

PMID:
27025329
10.

Social determinants and inequalities in tuberculosis incidence in Latin America and the Caribbean.

Munayco CV, Mújica OJ, León FX, del Granado M, Espinal MA.

Rev Panam Salud Publica. 2015 Sep;38(3):177-85.

11.

Leptospirosis in Rio Grande do Sul, Brazil: An Ecosystem Approach in the Animal-Human Interface.

Schneider MC, Najera P, Pereira MM, Machado G, dos Anjos CB, Rodrigues RO, Cavagni GM, Muñoz-Zanzi C, Corbellini LG, Leone M, Buss DF, Aldighieri S, Espinal MA.

PLoS Negl Trop Dis. 2015 Nov 12;9(11):e0004095. doi: 10.1371/journal.pntd.0004095. eCollection 2015 Nov.

12.

Malaria in the Americas: trends from 1959 to 2011.

Carter KH, Singh P, Mujica OJ, Escalada RP, Ade MP, Castellanos LG, Espinal MA.

Am J Trop Med Hyg. 2015 Feb;92(2):302-16. doi: 10.4269/ajtmh.14-0368. Epub 2014 Dec 29.

13.

Socioeconomic factors and vulnerability to outbreaks of leptospirosis in Nicaragua.

Bacallao J, Schneider MC, Najera P, Aldighieri S, Soto A, Marquiño W, Sáenz C, Jiménez E, Moreno G, Chávez O, Galan DI, Espinal MA.

Int J Environ Res Public Health. 2014 Aug 15;11(8):8301-18. doi: 10.3390/ijerph110808301.

14.

Phylogenetic evidence of a new canine distemper virus lineage among domestic dogs in Colombia, South America.

Espinal MA, Díaz FJ, Ruiz-Saenz J.

Vet Microbiol. 2014 Aug 6;172(1-2):168-76. doi: 10.1016/j.vetmic.2014.05.019. Epub 2014 May 27.

PMID:
24950886
15.

Where does human plague still persist in Latin America?

Schneider MC, Najera P, Aldighieri S, Galan DI, Bertherat E, Ruiz A, Dumit E, Gabastou JM, Espinal MA.

PLoS Negl Trop Dis. 2014 Feb 6;8(2):e2680. doi: 10.1371/journal.pntd.0002680. eCollection 2014 Feb.

16.

Leptospirosis: a silent epidemic disease.

Schneider MC, Jancloes M, Buss DF, Aldighieri S, Bertherat E, Najera P, Galan DI, Durski K, Espinal MA.

Int J Environ Res Public Health. 2013 Dec 16;10(12):7229-34. doi: 10.3390/ijerph10127229.

17.

Progress towards eliminating canine rabies: policies and perspectives from Latin America and the Caribbean.

Vigilato MA, Clavijo A, Knobl T, Silva HM, Cosivi O, Schneider MC, Leanes LF, Belotto AJ, Espinal MA.

Philos Trans R Soc Lond B Biol Sci. 2013 Jun 24;368(1623):20120143. doi: 10.1098/rstb.2012.0143. Print 2013 Aug 5. Review.

18.

Cardiovascular disease mortality in the Americas: current trends and disparities.

de Fatima Marinho de Souza M, Gawryszewski VP, Orduñez P, Sanhueza A, Espinal MA.

Heart. 2012 Aug;98(16):1207-12. doi: 10.1136/heartjnl-2012-301828.

PMID:
22826558
19.

WHO's relationship with the Stop TB Partnership.

Espinal MA.

Lancet. 2012 Feb 18;379(9816):612. doi: 10.1016/S0140-6736(12)60158-5. Epub 2012 Jan 30. No abstract available.

PMID:
22293366
20.

The Stop TB Partnership and the role of The Union.

Espinal MA.

Int J Tuberc Lung Dis. 2008 Nov;12(11):1221-2. No abstract available.

PMID:
18926029
21.

Multidrug-resistant tuberculosis management in resource-limited settings.

Nathanson E, Lambregts-van Weezenbeek C, Rich ML, Gupta R, Bayona J, Blöndal K, Caminero JA, Cegielski JP, Danilovits M, Espinal MA, Hollo V, Jaramillo E, Leimane V, Mitnick CD, Mukherjee JS, Nunn P, Pasechnikov A, Tupasi T, Wells C, Raviglione MC.

Emerg Infect Dis. 2006 Sep;12(9):1389-97.

22.

Tuberculosis as a major global health problem in the 21st century: a WHO perspective.

Gupta R, Espinal MA, Raviglione MC.

Semin Respir Crit Care Med. 2004 Jun;25(3):245-53.

PMID:
16088467
23.

Can DOTS control multidrug-resistant tuberculosis?

Espinal MA, Dye C.

Lancet. 2005 Apr 2-8;365(9466):1206-9. No abstract available.

PMID:
15811438
24.

Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative.

Nathanson E, Gupta R, Huamani P, Leimane V, Pasechnikov AD, Tupasi TE, Vink K, Jaramillo E, Espinal MA.

Int J Tuberc Lung Dis. 2004 Nov;8(11):1382-4.

PMID:
15581210
25.

Is second-line anti-tuberculosis drug susceptibility testing reliable?

Kim SJ, Espinal MA, Abe C, Bai GH, Boulahbal F, Fattorin L, Gilpin C, Hoffner S, Kam KM, Martin-Casabona N, Rigouts L, Vincent V.

Int J Tuberc Lung Dis. 2004 Sep;8(9):1157-8. No abstract available.

PMID:
15455606
26.

Eliminating tuberculosis: the time has come for business 'unusual'.

Espinal MA, Sarkar S.

Int J Tuberc Lung Dis. 2004 Mar;8(3):275. No abstract available.

PMID:
15139463
27.

Childhood tuberculosis: clinical research needs.

Graham SM, Gie RP, Schaaf HS, Coulter JB, Espinal MA, Beyers N.

Int J Tuberc Lung Dis. 2004 May;8(5):648-57. Review.

PMID:
15137549
28.

Time to abandon the standard retreatment regimen with first-line drugs for failures of standard treatment.

Espinal MA.

Int J Tuberc Lung Dis. 2003 Jul;7(7):607-8. No abstract available.

PMID:
12870678
29.

The global situation of MDR-TB.

Espinal MA.

Tuberculosis (Edinb). 2003;83(1-3):44-51. Review.

PMID:
12758188
30.

Towards optimization of surveillance resistance to antituberculosis drug resistance.

Raviglione MC, Espinal MA.

Euro Surveill. 2000 Oct;5(10):103-104.

PMID:
12631964
31.

Increasing transparency in partnerships for health--introducing the Green Light Committee.

Gupta R, Cegielski JP, Espinal MA, Henkens M, Kim JY, Lambregts-Van Weezenbeek CS, Lee JW, Raviglione MC, Suarez PG, Varaine F.

Trop Med Int Health. 2002 Nov;7(11):970-6.

32.

Rebuttal: Evidence and uncertainties.

Gupta R, Espinal MA, Raviglione MC.

Int J Tuberc Lung Dis. 2002 Aug;6(8):651-3. No abstract available.

PMID:
12150474
33.

Will tuberculosis become resistant to all antibiotics?

Dye C, Espinal MA.

Proc Biol Sci. 2001 Jan 7;268(1462):45-52.

34.

Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru.

Suárez PG, Floyd K, Portocarrero J, Alarcón E, Rapiti E, Ramos G, Bonilla C, Sabogal I, Aranda I, Dye C, Raviglione M, Espinal MA.

Lancet. 2002 Jun 8;359(9322):1980-9.

PMID:
12076553
35.

Worldwide incidence of multidrug-resistant tuberculosis.

Dye C, Espinal MA, Watt CJ, Mbiaga C, Williams BG.

J Infect Dis. 2002 Apr 15;185(8):1197-202. Epub 2002 Apr 1.

PMID:
11930334
36.

The global tuberculosis situation. Progress and problems in the 20th century, prospects for the 21st century.

Cegielski JP, Chin DP, Espinal MA, Frieden TR, Rodriquez Cruz R, Talbot EA, Weil DE, Zaleskis R, Raviglione MC.

Infect Dis Clin North Am. 2002 Mar;16(1):1-58. Review.

PMID:
11917808
37.

Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis.

Dye C, Williams BG, Espinal MA, Raviglione MC.

Science. 2002 Mar 15;295(5562):2042-6. Review.

PMID:
11896268
38.

The burden of drug-resistant tuberculosis and mechanisms for its control.

Raviglione MC, Gupta R, Dye CM, Espinal MA.

Ann N Y Acad Sci. 2001 Dec;953:88-97. Review.

PMID:
11795426
39.

Should tuberculosis programmes invest in second-line treatments for multidrug-resistant tuberculosis (MDR-TB)?

Gupta R, Raviglione MC, Espinal MA.

Int J Tuberc Lung Dis. 2001 Dec;5(12):1078-9. Review. No abstract available.

PMID:
11769764
40.

Determinants of drug-resistant tuberculosis: analysis of 11 countries.

Espinal MA, Laserson K, Camacho M, Fusheng Z, Kim SJ, Tlali RE, Smith I, Suarez P, Antunes ML, George AG, Martin-Casabona N, Simelane P, Weyer K, Binkin N, Raviglione MC.

Int J Tuberc Lung Dis. 2001 Oct;5(10):887-93.

PMID:
11605880
41.

The future may not be so dark.

Espinal MA, Gupta R, Raviglione MC.

Int J Tuberc Lung Dis. 2001 Sep;5(9):787-8. No abstract available.

PMID:
11573888
42.

The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru.

Suárez PG, Watt CJ, Alarcón E, Portocarrero J, Zavala D, Canales R, Luelmo F, Espinal MA, Dye C.

J Infect Dis. 2001 Aug 15;184(4):473-8. Epub 2001 Jul 18.

PMID:
11471105
43.

Public health. Responding to market failures in tuberculosis control.

Gupta R, Kim JY, Espinal MA, Caudron JM, Pecoul B, Farmer PE, Raviglione MC.

Science. 2001 Aug 10;293(5532):1049-51. Epub 2001 Jul 19. No abstract available.

PMID:
11463877
44.

Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

Espinal MA, Laszlo A, Simonsen L, Boulahbal F, Kim SJ, Reniero A, Hoffner S, Rieder HL, Binkin N, Dye C, Williams R, Raviglione MC.

N Engl J Med. 2001 Apr 26;344(17):1294-303.

45.

Transesophageal Echocardiographic Examination of Left Subclavian Artery Branches.

Nanda NC, Thakur AC, Thakur D, Narayan VK, Espinal MA, Shoeb G, Samal AK, Voros S, Aaluri SR, Ocak O, John AS, Pasia AT, Aikens M.

Echocardiography. 1999 Apr;16(3):271-277.

PMID:
11175150
46.

Three-Dimensional Echocardiographic Assessment of Aortic Dissection.

Nanda NC, Khatri GK, Samal AK, Abd El-Rahman SM, Thakur AC, Jamil F, Moursi M, John AS, Aaluri SR, de Sousa JB Jr, Aggarwal R, Shoeb G, Espinal MA, Kumar Narayan V V.

Echocardiography. 1998 Nov;15(8 Pt 1):745-754.

PMID:
11175107
47.

Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.

Gupta R, Espinal MA, Raviglione MC.

Int J Tuberc Lung Dis. 2000 Nov;4(11):1089-91. No abstract available.

PMID:
11092726
48.

Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.

Espinal MA, Kim SJ, Suarez PG, Kam KM, Khomenko AG, Migliori GB, Baéz J, Kochi A, Dye C, Raviglione MC.

JAMA. 2000 May 17;283(19):2537-45.

PMID:
10815117
49.

Infectiousness of Mycobacterium tuberculosis in HIV-1-infected patients with tuberculosis: a prospective study.

Espinal MA, Peréz EN, Baéz J, Hénriquez L, Fernández K, Lopez M, Olivo P, Reingold AL.

Lancet. 2000 Jan 22;355(9200):275-80.

PMID:
10675075
50.

Rational 'DOTS plus' for the control of MDR-TB.

Espinal MA, Dye C, Raviglione M, Kochi A.

Int J Tuberc Lung Dis. 1999 Jul;3(7):561-3. Review. No abstract available.

PMID:
10423218

Supplemental Content

Loading ...
Support Center